We evaluated cardiovascular event data for valdecoxib , a new COX-2-specific inhibitor in approximately 8000 patients with osteoarthritis and rheumatoid arthritis treated with this agent in randomized clinical trials .
O O O O O O B-ChemicalEntity O O O B-GeneOrGeneProduct O O O O B-OrganismTaxon O B-DiseaseOrPhenotypicFeature O B-DiseaseOrPhenotypicFeature I-DiseaseOrPhenotypicFeature O O O O O O O O O